TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING NUMBER OF ELECTROSURGERY PROCEDURES
4.2.2 INCREASING DEVELOPMENTS IN MINIMALLY INVASIVE SURGICAL EQUIPMENT
4.2.3 INCREASED PRODUCT DEVELOPMENT
4.3 RESTRAINTS
4.3.1 RISKS ASSOCIATED WITH TOXIC FUMES PRODUCED DURING SURGICAL PROCEDURES
4.3.2 LIMITED CLINICAL EVIDENCE TO ESTABLISH OPERATIONAL EFFICACY OF TARGET PRODUCTS
4.4 OPPORTUNITIES
4.4.1 INCREASING DEMAND IN EMERGING COUNTRIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES SERVICES AND REVIEW
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON COST OF RAW MATERIALS
5.3.2 IMPACT ON THE AVAILABILITY OF PRODUCTS
5.3.3 IMPACT ON PRODUCTION FACILITIES OF MAJOR MANUFACTURERS
5.3.4 IMPACT ON TRADE (IMPORT/EXPORT)
6 GLOBAL SMOKE EVACUATION DEVICE MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 SMOKE EVACUATION FILTERS
6.2.1 ULPA FILTERS
6.2.2 CHARCOAL FILTERS
6.2.3 IN-LINE FILTERS
6.2.4 PRE-FILTERS
6.3 SMOKE EVACUATION PENCILS & WANDS
6.4 SMOKE-EVAC FUSION COMPONENTS (SHROUDS)
6.5 SMOKE EVACUATION TUBINGS
6.6 ACCESSORIES
7 GLOBAL SMOKE EVACUATION DEVICEMARKET, BY MODALITY
7.1 OVERVIEW
7.2 STATIONARY SYSTEMS
7.3 PORTABLE SYSTEMS
8 GLOBAL SMOKE EVACUATION DEVICE MARKET, BY TYPE OF SURGERY
8.1 OVERVIEW
8.2 GENERAL SURGERY
8.3 OBSTETRICS/GYNECOLOGY SURGERY
8.4 UROLOGICAL SURGERY
8.5 ORTHOPEDIC SURGERY
8.6 CARDIOVASCULAR SURGERY
8.7 COSMETIC SURGERY
8.8 NEUROSURGERY
8.9 ONCOLOGICAL SURGERY
8.10 OTHERS
9 GLOBAL SMOKE EVACUATION DEVICE MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS AND CLINICS
9.3 AMBULATORY SURGICAL CENTERS
9.4 OTHERS
10 GLOBAL SMOKE EVACUATION DEVICE MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 NETHERLANDS
10.3.7 NORWAY
10.3.8 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE SMOKE EVACUATION DEVICE MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN SMOKE EVACUATION DEVICE MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
11.6.2 BUSINESS EXPANSIONS/AGREEMENTS
11.6.3 MERGERS & ACQUISITIONS
11.7 MAJOR PLAYERS SALES ANALYSIS
11.7.1 SALES & OPERATING INCOME
11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILES
12.1 MEDTRONIC
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 ZIMMER BIOMET
12.2.1 COMPANY OVERVIEWS
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 KEY STRATEGIES
12.3 JOHNSON & JOHNSON SERVICES, INC.
12.3.1 COMPANY OVERVIEWS
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 DANAHER
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 KLS MARTIN GROUP
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIES
12.6 STRYKER
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL ANALYSIS
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 OLYMPUS CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 STERIS
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS 0FFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 CONMED CORPORATION
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 SYMMETRY SURGICAL INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL ANALYSIS
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer